Table 4

Incidence of clinical neuropathy, abnormal NCSs, and confirmed clinical neuropathy at DCCT closeout and EDIC years 13–14 among subjects who did not fulfill the specific criterion for neuropathy at the preceding evaluation

VariableDCCT baselineDCCT closeoutEDIC years 13–14
Clinical neuropathy
    INT57/600 (10)57/533 (11)145/505 (29)
    CONV48/581 (8)96/526 (18)154/448 (34)
Abnormal NCSs
    INT185/601 (31)73/410 (18)195/430 (45)
    CONV196/582 (34)137/382 (36)151/290 (52)
Confirmed clinical neuropathy
    INT39/600 (7)32/551 (6)117/541 (22)
    CONV31/581 (5)75/543 (14)136/479 (28)
  • Data are n (%).

  • P < 0.001 former intensive treatment group (INT) vs. former conventional treatment group (CONV).

  • P = 0.125.